Published in Arch Immunol Ther Exp (Warsz) on January 03, 2013
Perinatal Licensing of Thermogenesis by IL-33 and ST2. Cell (2016) 1.43
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. Immunity (2015) 1.37
Type II cytokines impair host defense against an intracellular fungal pathogen by amplifying macrophage generation of IL-33. Mucosal Immunol (2014) 0.81
Role of IL-33 and its receptor in T cell-mediated autoimmune diseases. Biomed Res Int (2014) 0.79
Evaluation of the circulating levels of IL-12 and IL-33 in patients with breast cancer: influences of the tumor stages and cytokine gene polymorphisms. Iran J Basic Med Sci (2015) 0.77
The role of IL-33 in host response to Candida albicans. ScientificWorldJournal (2014) 0.76
STAT3 and ERK pathways are involved in cell growth stimulation of the ST2/IL1RL1 promoter. FEBS Open Bio (2017) 0.75
Serum Interleukin-33 level in Saudi children with inflammatory bowel disease. Int J Clin Exp Pathol (2015) 0.75
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis. Oman Med J (2016) 0.75
Detection of soluble ST2 in human follicular fluid and luteinized granulosa cells. PLoS One (2013) 0.75
The role of ST2 and ST2 genetic variants in schistosomiasis. J Allergy Clin Immunol (2017) 0.75
Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol (2005) 9.70
Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A (2006) 3.70
IL-33 reduces the development of atherosclerosis. J Exp Med (2008) 3.59
IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol (2009) 3.41
IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol (2008) 3.31
ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol (2004) 3.19
TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A (2004) 3.04
IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol (2008) 2.83
IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol (2007) 2.43
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med (2010) 2.38
Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med (2009) 2.24
CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol (2003) 2.19
Retracted The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A (2009) 2.15
Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med (2004) 2.08
Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res (2010) 1.80
IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol (2010) 1.73
Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol (2004) 1.72
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A (2008) 1.67
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis (2010) 1.62
A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol (2004) 1.55
Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol (2010) 1.45
IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages. Eur J Immunol (2012) 1.43
T1/ST2--an IL-1 receptor-like modulator of immune responses. Cytokine Growth Factor Rev (2004) 1.43
TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol (2005) 1.41
Schistosome-derived omega-1 drives Th2 polarization by suppressing protein synthesis following internalization by the mannose receptor. J Exp Med (2012) 1.32
Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J Immunol (2008) 1.29
Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol (2009) 1.28
IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One (2012) 1.25
Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J Immunol (2002) 1.23
Regulatory B-cell induction by helminths: implications for allergic disease. J Allergy Clin Immunol (2011) 1.17
Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One (2012) 1.15
Sustained IL-12 signaling is required for Th1 development. J Immunol (2004) 1.15
TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. J Immunol (2011) 1.13
Systemic autoimmune disease induced by dendritic cells that have captured necrotic but not apoptotic cells in susceptible mouse strains. Eur J Immunol (2005) 1.12
Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) (2009) 1.11
Helminths and dendritic cells: sensing and regulating via pattern recognition receptors, Th2 and Treg responses. Eur J Immunol (2010) 1.08
Glucocorticoid-induced TNFR family-related protein (GITR) activation exacerbates murine asthma and collagen-induced arthritis. Eur J Immunol (2005) 1.08
Regulatory T cells in human lymphatic filariasis: stronger functional activity in microfilaremics. PLoS Negl Trop Dis (2012) 1.07
Interleukin-33 exacerbates acute colitis via interleukin-4 in mice. Immunology (2013) 1.07
ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol (2006) 1.03
T-helper 17 cells are associated with pathology in human schistosomiasis. J Infect Dis (2012) 1.02
IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol (2011) 1.01
Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol Lett (2004) 0.98
Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis (2011) 0.98
Functional impairment of human myeloid dendritic cells during Schistosoma haematobium infection. PLoS Negl Trop Dis (2010) 0.97
Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22. Eur Cytokine Netw (2004) 0.97
ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells. J Immunol (2004) 0.95
Chemoattraction of human T cells by IL-18. J Immunol (2003) 0.95
A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood (2009) 0.95
Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex. Eur J Immunol (2009) 0.94
Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies. Cell Mol Immunol (2010) 0.94
A novel negative regulator for IL-1 receptor and Toll-like receptor 4. Immunol Lett (2005) 0.92
Asymptomatic plasmodial infection is associated with increased tumor necrosis factor receptor II-expressing regulatory T cells and suppressed type 2 immune responses. J Infect Dis (2013) 0.92
A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med (2007) 0.91
Administration of exogenous interleukin-18 and interleukin-12 prevents the induction of oral tolerance. Immunology (2003) 0.89
Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors. Int J Parasitol (2012) 0.89
An essential protective role of IL-10 in the immunological mechanism underlying resistance vs. susceptibility to lupus induction by dendritic cells and dying cells. Rheumatology (Oxford) (2011) 0.89
CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry. J Histochem Cytochem (2002) 0.88
Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15. Eur J Immunol (2008) 0.88
A crucial role for dendritic cell (DC) IL-10 in inhibiting successful DC-based immunotherapy: superior antitumor immunity against hepatocellular carcinoma evoked by DC devoid of IL-10. J Immunol (2007) 0.86
Anti-interleukin-33 inhibits cigarette smoke-induced lung inflammation in mice. Immunology (2013) 0.86
Attenuated bacteria as effectors in cancer immunotherapy. Ann N Y Acad Sci (2008) 0.84
TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium. Immunol Cell Biol (2008) 0.83
Alterations in peripheral blood B cell subsets and dynamics of B cell responses during human schistosomiasis. PLoS Negl Trop Dis (2013) 0.82
The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-β. PLoS One (2013) 0.82
Differential responses of cord and adult blood-derived dendritic cells to dying cells. Immunology (2005) 0.82
Toll-like receptor ligation for the induction of regulatory B cells. Methods Mol Biol (2014) 0.80
Rapamycin and omega-1: mTOR-dependent and -independent Th2 skewing by human dendritic cells. Immunol Cell Biol (2013) 0.80
Association of ICAM3 genetic variant with severe acute respiratory syndrome. J Infect Dis (2007) 0.79
Anti-Toll-like receptor 2 and 4 antibodies suppress inflammatory response in mice. Immunology (2014) 0.79
Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients. Mediators Inflamm (2012) 0.78
Potential of immunoglobulin A to prevent allergic asthma. Clin Dev Immunol (2013) 0.78
Uptake of antigens from the intestine by dendritic cells. Ann N Y Acad Sci (2004) 0.77
A novel function for dendritic cell: clearance of VEGF via VEGF receptor-1. Biochem Biophys Res Commun (2009) 0.77
Activation of innate immune responses by IL-2-expressing Salmonella typhimurium is independent of Toll-like receptor 4. Mol Immunol (2004) 0.76
Antiviral treatment improves disrupted peripheral B lymphocyte homeostasis in chronic hepatitis B virus-infected patients. Exp Biol Med (Maywood) (2013) 0.76
Innate, adaptive and regulatory responses in schistosomiasis: relationship to allergy. Chem Immunol Allergy (2006) 0.76
Retraction. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A (2012) 0.75
A highly optimized protocol for reprogramming cancer cells to pluripotency using nonviral plasmid vectors. Cell Reprogram (2014) 0.75
Microorganism-induced suppression of allergic airway disease: novel therapies on the horizon? Expert Rev Respir Med (2014) 0.75
Modeling COVID-19 with Human Pluripotent Stem Cell-Derived Cells Reveals Synergistic Effects of Anti-inflammatory Macrophages with ACE2 Inhibition Against SARS-CoV-2. Res Sq (2020) 0.75